National Bank of Canada’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Buy
7,994
+627
+9% +$27K ﹤0.01% 1484
2025
Q4
$323K Buy
7,367
+1,247
+20% +$51.6K ﹤0.01% 1463
2025
Q3
$253K Sell
6,120
-2,237
-27% -$89.9K ﹤0.01% 1492
2025
Q2
$368K Buy
8,357
+1,953
+30% +$78.1K ﹤0.01% 1472
2025
Q1
$236K Buy
+6,404
New +$228K ﹤0.01% 1490
2024
Q2
Sell
-83,000
Closed -$1.77M 2743
2024
Q1
$1.77M Buy
+83,000
New +$1.84M ﹤0.01% 1031
2023
Q2
Sell
-166,000
Closed -$3.22M 2752
2023
Q1
$3.22M Buy
166,000
+75,000
+82% +$1.31M 0.01% 723
2022
Q4
$1.46M Buy
+91,000
New +$1.48M ﹤0.01% 961

Other funds holding EXEL

National Bank of Canada's EXEL Position: Q1 2026 in Review

National Bank of Canada increased its Exelixis (EXEL) stake by 8.5% in Q1 2026, buying an estimated $27K and bringing the position to 7,994 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

National Bank of Canada first reported a position in EXEL in Q4 2022 and has held it in 8 quarters since. The position peaked at $3.22M in Q1 2023. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • National Bank of Canada held 7,994 shares of Exelixis worth $343K as of Q1 2026.
  • National Bank of Canada bought 627 Exelixis shares in Q1 2026, an estimated $27K.
  • Exelixis made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1484 holding.
  • National Bank of Canada first reported a position in Exelixis in Q4 2022 and has held it in 8 quarters since.
  • National Bank of Canada's Exelixis position peaked at $3.22M in Q1 2023.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.